Wolfgang Wa Schamel

19PUBLICATIONS
107CO-AUTHORS
Innate immunityProteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)Hybrid and electric vehicles and powertrainsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 03, 2025
Development of a Peptide Inhibitor Targeting the C-SH2 Domain of the SHP2 Phosphatase.

Azin Kiani, Catia L Pierotti, Franziska Schedel

|Jan 04, 2025
Allosteric Changes Underlie the Outside-In Transmission of Activatory Signals in the TCR.

Balbino Alarcon, Wolfgang W Schamel

|Oct 21, 2024
From TCR fundamental research to innovative chimeric antigen receptor design.

Susana Minguet, Marcela V Maus, Wolfgang W Schamel

|Sep 04, 2024
TCR/CD3-based synthetic antigen receptors (TCC) convey superior antigen sensitivity combined with high fidelity of activation.

Vanessa Mühlgrabner, Timo Peters, Rubí M-H Velasco Cárdenas

|Mar 15, 2024
Kidins220 and Aiolos promote thymic iNKT cell development by reducing TCR signals.

Laurenz A Herr, Gina J Fiala, Sagar

Pageof 4